Dr. Stefan Thiel Programme Director

Life Sciences 3: Medicine
E-mail: stefan.thiel@dfg.de Telephone: +49 (228) 885-2977 Telefax: +49 (228) 885-713320

Kennedyallee 40
53175 Bonn


General Responsibilities
Clinical Trials
Coordination - Cancer Research
Support of DFG Statutory Bodies
Hinterzarten Circle on Cancer Research
Sektion 2 des Fachkollegiums Medizin

Scientific Areas of Responsibility

Main Contact
2.22-14 Hematology, Oncology
Deputy Contact
2.22-03 Human Genetics
2.22-06 Pathology
2.22-15 Gastroenterology
2.22-16 Nephrology
2.22-20 Pediatric and Adolescent Medicine
2.22-23 Reproductive Medicine, Urology

Coordinated Programmes (scientific matters)

2180 Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
2375 Tumor-Targeted Drug Delivery
2573 The inflammatory tumor secretome – from understanding to novel therapies
387 Functionalizing the Ubiquitin System against Cancer - UbiQancer
1399 Mechanisms of drug sensitivity and resistance in small cell lung cancer
1479 Oncogene-driven immune escape (OncoEscape)
1530 Elucidation and targeting of pathogenic mechanisms in B cell malignancies

Coordinated Programmes (procedural matters)

2033 The Hematopoietic Niches
2314 Targeting therapeutic windows in essential cellular processes for tumor therapy
2674 Aging-related epigenetic remodeling in acute myeloid leukemia
5433 RNA in focus (RIF): From mechanisms to novel therapeutic strategies in cancer treatment
5643 Clonal hematopoiesis: Pathomechanisms and clinical consequences in the heart and blood
5659 TARGET-MPN: TARgetinG disease pErsisTence and progression of MyeloProliferative Neoplasms (MPN)
Klinische Forschungsgruppe
344 Untangling and Targeting Mechanisms of Myelofibrosis in Myeloproliferative Neoplasms (MPN)
5010 CATCH ALL Towards a Cure for Adults and Children with Acute Lymphoblastic Leukemia (ALL)